Merle Myerson

Summary

Country: USA

Publications

  1. doi Lipid Management in Human Immunodeficiency Virus
    Merle Myerson
    Cardiovascular Disease Prevention Program and Lipid Clinic, Cardiology Section, Institute for Advanced Medicine HIV, Mount Sinai St Luke s, Mount Sinai Roosevelt, 1111 Amsterdam Avenue, New York, NY 10025, USA Electronic address
    Endocrinol Metab Clin North Am 45:141-69. 2016
  2. doi Lipid management in human immunodeficiency virus
    Merle Myerson
    Cardiovascular Disease Prevention Program and Lipid Clinic, Cardiology Section, Institute for Advanced Medicine HIV, Mount Sinai St Luke s, Mount Sinai Roosevelt, 1111 Amsterdam Avenue, New York, NY 10025, USA Electronic address
    Cardiol Clin 33:277-98. 2015
  3. doi Preparticipation athletic screening for genetic heart disease
    Merle Myerson
    Cardiovascular Disease Prevention Program, St Luke s and Roosevelt Hospitals, New York, NY, USA
    Prog Cardiovasc Dis 54:543-52. 2012
  4. doi Declining severity of myocardial infarction from 1987 to 2002: the Atherosclerosis Risk in Communities (ARIC) Study
    Merle Myerson
    EdD, Director, Cardiovascular Disease Prevention Program, Division of Cardiology, St Luke s Roosevelt Hospital of Columbia University, 1111 Amsterdam Ave, New York, NY 10025, USA
    Circulation 119:503-14. 2009

Collaborators

Detail Information

Publications4

  1. doi Lipid Management in Human Immunodeficiency Virus
    Merle Myerson
    Cardiovascular Disease Prevention Program and Lipid Clinic, Cardiology Section, Institute for Advanced Medicine HIV, Mount Sinai St Luke s, Mount Sinai Roosevelt, 1111 Amsterdam Avenue, New York, NY 10025, USA Electronic address
    Endocrinol Metab Clin North Am 45:141-69. 2016
    ..Issues for which there is little or no information available are noted to highlight the many gaps in our knowledge regarding diagnosis and management of dyslipidemia for patients living with HIV. ..
  2. doi Lipid management in human immunodeficiency virus
    Merle Myerson
    Cardiovascular Disease Prevention Program and Lipid Clinic, Cardiology Section, Institute for Advanced Medicine HIV, Mount Sinai St Luke s, Mount Sinai Roosevelt, 1111 Amsterdam Avenue, New York, NY 10025, USA Electronic address
    Cardiol Clin 33:277-98. 2015
    ..Issues for which there is little or no information available are noted to highlight the many gaps in our knowledge regarding diagnosis and management of dyslipidemia for patients living with HIV...
  3. doi Preparticipation athletic screening for genetic heart disease
    Merle Myerson
    Cardiovascular Disease Prevention Program, St Luke s and Roosevelt Hospitals, New York, NY, USA
    Prog Cardiovasc Dis 54:543-52. 2012
    ..Lastly, the importance of a response plan to an apparent SCD event that includes on-site/on-field automated external defibrillators will be discussed. A case study that illustrates the challenges in screening is presented...
  4. doi Declining severity of myocardial infarction from 1987 to 2002: the Atherosclerosis Risk in Communities (ARIC) Study
    Merle Myerson
    EdD, Director, Cardiovascular Disease Prevention Program, Division of Cardiology, St Luke s Roosevelt Hospital of Columbia University, 1111 Amsterdam Ave, New York, NY 10025, USA
    Circulation 119:503-14. 2009
    ..We hypothesized that for those patients hospitalized in the Atherosclerosis Risk in Communities (ARIC) Study with acute incident MI, there was a decline in MI severity from 1987 to 2002...